Search

Your search keyword '"Fumery M"' showing total 580 results

Search Constraints

Start Over You searched for: Author "Fumery M" Remove constraint Author: "Fumery M"
580 results on '"Fumery M"'

Search Results

2. Severe erosive gingivostomatitis in a patient treated by vedolizumab

4. P927 Long-term outcomes of risankizumab in Crohn’s disease: a multicenter GETAID Study

5. P386 Persistence of bowel urgency despite clinical remission after induction therapy is associated with unfavorable long-term outcomes in patients with ulcerative colitis: results from the multicenter UC-RGENCY study

6. DOP05 Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´s Disease

10. P857 Effectiveness and safety of subcutaneous infliximab in perianal Crohn's disease: a multicentre cohort study

12. P1071 Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID

13. P322 Compared Efficacy of Second-Line Treatments for Ulcerative Colitis After Failure of Vedolizumab in First-Line Treatment: A Retrospective Multicenter Study

15. DOP79 Promising efficacy of biologicals and small molecules for microscopic colitis: results from a large real-life multicenter cohort

17. P679 Anti-TNF de-escalation following a treat-to-target strategy with golimumab therapy intensification to reach continuous clinical response in ulcerative colitis: the In-Target GETAID trial

19. DOP23 The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohort

21. P226 Disability in Crohn’s Disease Patients at diagnosis: Findings from the CROCO (Crohn´s Disease Cohort) study

26. Long‐term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH‐LT study.

28. Disease course of Crohn's disease during the first ten years following diagnosis in a prospective European population-based inception cohort - the Epi-IBD cohort

29. Disease course of Ulcerative Colitis during the first ten years following diagnosis in a prospective European population-based inception cohort - the Epi-IBD cohort

30. Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn′s Disease: A French Population-Based Study

33. P443 Risk of incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: a Multicentre Cohort Study

35. P299 Disability in newly diagnosed patients with Crohn′s Disease: initial results from the prospective CROCO (Crohn′s Disease Cohort) Study

38. P155 Natural history of anal stricture in pediatric-onset Crohn’s disease: a two-decades population-based study

40. P579 Real-world comparison of effectiveness between tofacitinib and ustekinumab in patients with ulcerative colitis exposed to at least one anti-TNF agent: results from the TORUS study

43. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab

44. Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort

46. DOP019 Immunomodulators reduce the risk of surgery and hospitalisation in Crohn’s disease in a prospective European population-based inception cohort: the Epi-IBD cohort

49. Efficacy and safety of golimumab in Crohnʼs disease: a French national retrospective study

50. Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study

Catalog

Books, media, physical & digital resources